相关细胞因子对不孕症的影响分析及育龄期女性子宫内膜异位症预测模型构建

doi:10.3969/j.issn.1006-6233.2024.03.025

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1368 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要 目的:分析相关细胞因子对不孕症的影响,并建立育龄期女性子宫内膜异位症治疗后不孕症的预测模型。方法:纳入2020年3月至2022年3月医院108例育龄期女性子宫内膜异位症患者,所有患者入院时均接受血清学检测。随访1年,观察其自然妊娠情况,依据妊娠结果分为自然妊娠组与不孕组,对比两组基线资料及血清学检测指标,建立育龄期女性子宫内膜异位症预测模型,并分析相关细胞因子对不孕症的影响。结果:随访1年,108例育龄期女性子宫内膜异位症患者中成功妊娠66例(61.11%),未成功妊娠42例(38.89%);不孕组子宫内膜异位症Ⅲ期-Ⅳ期、未接受促排卵治疗的患者占比高于自然妊娠组(χ²=6.495、5.945,P<0.05);不孕组白细胞介素-1β(IL-1β)、白细胞介素-18(IL-18)、肿瘤坏死因子-α(TNF-α)水平高于自然妊娠组(t=7.345、4.095、5.739,P<0.05);绘制血清学细胞因子预测育龄期女性子宫内膜异位症患者发生不孕症的受试者工作曲线(ROC),结果显示,IL-1β、IL-18、TNF-α水平对育龄期女性子宫内膜异位症患者发生不孕症具有一定预测价值(AUC=0.837、0.711、0.779,P<0.05),联合预测价值更高(AUC=0.864);经Logistic回归分析,结果显示,子宫内膜异位症Ⅲ期-Ⅳ期、未接受促排卵治疗、高IL-1β、IL-18、TNF-α水平是育龄期女性子宫内膜异位症患者发生不孕症的危险因素(OR=4.730、4.173、16.216、1.012、4.631,P<0.05),将其带入回归方程可得:Logit(P)=-15.285+1.554X1+1.429X2+2.786X3+0.012X4+1.533X5。结论:子宫内膜异位症Ⅲ期-Ⅳ期、未接受促排卵治疗、高IL-1β、IL-18、TNF-α水平是育龄期女性子宫内膜异位症患者发生不孕症的危险因素,建立的Logistic回归模型可预测育龄期女性子宫内膜异位症患者发生不孕症的可能性,有助于帮助医务人员识别不孕症高风险者。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	金凤梅
	马清杰
	付久园

关键词 ：子宫内膜异位症, 育龄期女性, 细胞因子, 不孕症

Abstract：Objective: To analyze the influence of related cytokines on infertility and to establish a prediction model for infertility after treatment of women of reproductive age with endometriosis.Methods: A total of 108 cases of women of reproductive age with endometriosis from March 2020 to March 2022 were included in the study. They were followed up for one year to observe their natural pregnancy. According to the pregnancy results, they were divided into natural pregnancy group and infertility group. The baseline data and serological test indicators of the two groups were compared to establish a female endometriosis model of reproductive age and analyze the effects of related cytokines on infertility. Results: One year follow-up showed that among 108 women of reproductive age with endometriosis, 66 cases (61.11%) were pregnant successfully and 42 cases (38.89%) were not. The proportion of patients with endometriosis in stage Ⅲ~Ⅳ and not receiving ovulation induction in the infertility group was higher than that in the natural pregnancy group (χ²=6.495 and 5.945, P<0.05). The levels of IL-1β, IL-18 and TNF-α in the infertility group were higher than those in the natural pregnancy group (t=7.345, 4.095, 5.739, P<0.05). The ROC curve of serum cytokine levels predicting infertility in women of reproductive age with endometriosis was drawn, and the results showed that IL-1β, IL-18, and TNF-α levels had certain predictive value for infertility in women of reproductive age with endometriosis (AUC=0.837, 0.711, 0.779, P<0.05). After logistic regression analysis, the results showed that endometriosis stage Ⅲ~Ⅳ, not receiving ovulation induction therapy, high IL-1β, IL-18, and TNF-α levels were risk factors for infertility in female endometriosis patients of reproductive age (OR = 4.730, 4.173, 16.216, 1.012, and 4.631, P<0.05), which was brought into the regression equation to obtain: logit (P) = -15.285 + 1.554X1 + 1.429X2 + 2.786X3 + 0.012X4 + 1.533X5. Conclusion: Endometriosis stage Ⅲ~Ⅳ, not receiving ovulation induction therapy, high IL-1β, IL-18, and TNF-α levels are the risk factors for infertility in women of childbearing age with endometriosis. The established Logistic regression model can predict the possibility of infertility in women of childbearing age with endometriosis, and it is helpful for medical staff to identify high-risk infertility patients.

Key words： Endometriosis Women of reproductive age Cytokines Barrenness

基金资助:2020年承德市科学技术研究与发展计划项目,(编号:202006A017)

通讯作者: 马清杰

引用本文:

金凤梅, 马清杰, 付久园. 相关细胞因子对不孕症的影响分析及育龄期女性子宫内膜异位症预测模型构建[J]. 河北医学, 2024, 30(3): 488-492.
JIN Fengmei, MA Qingjie, et al. Analysis of the Effects of Relevant Cytokines on Infertility and Construction of a Predictive Model for Endometriosis in Women of Reproductive Age. HeBei Med, 2024, 30(3): 488-492.

链接本文:

http://www.hbyxzzs.cn/CN/10.3969/j.issn.1006-6233.2024.03.025 或 http://www.hbyxzzs.cn/CN/Y2024/V30/I3/488

[1] Giudice L C,As-Sanie S,Ferreira J,et al.Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain:two replicate phase 3,randomised,double-blind,studies (SPIRIT 1 and 2)[J].Lancet,2022,399(10343):2267-2279.
[2] Darici E,Salama M,Bokor A,et al.Different segmental resection techniques and postoperative complications in patients with colorectal endometriosis:a systematic review[J].Acta obstet gynecol Scand,2022,101(7):705-718.
[3] Christ JP,Yu O,Schulze-Rath R,et al.Incidence,prevalence,and trends in endometriosis diagnosis:a united states population-based study from 2006 to 2015[J].AM Obstet gynecol,2021,225(5):500.
[4] Tempest N,Boyers M,Carter A,et al.P-306 Premenopausal women with a diagnosis of endometriosis have a significantly higher prevalence of a diagnosis or symptoms suggestive of restless leg syndrome; prospective cross-sectional study[J].Hum Reprod,2021,29(12):599306.
[5] 中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症的诊治指南[J].中华妇产科杂志,2015,50(3):161-169.
[6] Masuda H,Schwab K E,Filby C E,et al.Endometrial stem/progenitor cells in menstrual blood and peritoneal fluid of women with and without endometriosis[J].Reprod biomed online,2021,43(1):3-13.
[7] Keckstein J,Hudelist G.Classification of deep endometriosis (DE) including bowel endometriosis:from r-ASRM to #Enzian-classification[J].Best pract res Clin obstet gynaecol,2021,71(1):27-37.
[8] 曾湘晖,王莉云,纪冰.子宫内膜异位症合并不孕患者IVF治疗采用不同促排卵方案的妊娠结局比较[J].实用妇产科杂志,2020,36(2):145-148.
[9] Jaafar S H,Sallam H N,Arici A,et al.Long-term GnRH agonist therapy before in vitro fertilization (IVF) for improving fertility outcomes in women with endometriosis[J].Cochrane database syst rev (Online),2019,20(11):13240.
[10] Evangelisti G,Ferrero S,Barra F.Gonadotropin-releasing hormone (GnRH) receptor antagonist Treatment of uterine fibroids Treatment of endometriosis[J].Drug Future,2021,46(11):46.
[11] Carolina G,Lucian CM,Oana TD,et al.Pro-inflammatory cytokines (IL6,IL8 and TNF-alpha) in the evaluation of ovarian endometriosis cyst[J].Rev CHIM-BUCHAREST,2019,70(8):2944-2947.
[12] 梁毓,兰永连,李颖,等.子宫内膜异位症合并不孕患者卵泡液中细胞因子表达水平的研究[J].北京医学,2021,43(2):130-132,137.
[13] Peng B,Alotaibi F T,Sadaf S,et al.Role of interleukin-1β in nerve growth factor expression,neurogenesis and deep dyspareunia in endometriosis[J].Hum Reprod,2020,35(4):901-912.
[14] 胡晓燕.腹腔镜联合GnRH-a对子宫内膜异位症患者VEGF,IL-18及TNF-α的影响[J].湖南师范大学学报(医学版),2018,15(4):86-88.
[15] Peng Y,Ma J,Lin J.Activation of the CXCL16/CXCR6 axis by TNF-α contributes to ectopic endometrial stromal cells migration and invasion[J].Reprod Sci,2019,26(3):420-427.